SCHEMBL97654

SCHEMBL97654

CCC(C)C(=O)Oc1ccc(O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.46
ESR1 P03372 5/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
ESR2 Q92731 1/20 0.43
CA14 Q9ULX7 1/20 0.43
LMNA P02545 3/20 0.42
TSHR P16473 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
HIF1A Q16665 1/20 0.42
MAPK1 P28482 1/20 0.42
NR1H2 P55055 1/20 0.42
RNASEL Q05823 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CHRM1 P11229 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10359066 1.00 ELANE (0.46) ELANEESR1CA12CA1CA2
SCHEMBL9488299 0.95 ESR2 (0.44) ELANEESR1CA12CA1CA2
SCHEMBL12017408 0.89 ESR1 (0.47) ELANEESR1ESR2TSHRSMN1; SMN2
SCHEMBL10000787 0.87 ELANE (0.47) ELANEESR1TSHRCYP1A2CYP2C19
SCHEMBL25968326 0.87 ELANE (0.61) ELANEESR1CA2LMNATSHR
SCHEMBL20138640 0.86 ESR1 (0.44) ELANEESR1CA12CA1CA2
SCHEMBL26499157 0.85 ELANE (0.46) ELANEESR1CA1CA2LMNA
SCHEMBL12419169 0.85 LMNA (0.52) ELANEESR1LMNAHIF1AALDH1A1
SCHEMBL10053083 0.85 ESR1 (0.47) ESR1ESR2LMNAHSD17B10MEN1
SCHEMBL19222173 0.84 ELANE (0.44) ELANEESR1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240231225-A1 RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-11 US disclosed
CN-113646052-B Reversible thermochromic composition, reversible thermochromic microcapsule pigment, and writing instrument 百乐墨水株式会社 2024-05-17 CN disclosed
WO-2023213696-A1 DEVELOPMENT OF NOVEL NEUTRAL MATS CONTAINING HYDROXYL MONOMERS TO IMPROVE SIARC SUBSTRATE COMPATIBILITY FOR DIRECTED SELF-ASSEMBLY OF DIBLOCK COPOLYMERS MERCK PATENT GMBH (DE) 2023-11-09 WO disclosed
US-20230350290-A1 PATTERN FORMING METHOD, KIT, AND RESIST COMPOSITION FUJIFILM CORPORATION (JP) 2023-11-02 US disclosed
EP-4270108-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2023-11-01 EP disclosed
US-11773059-B2 Onium salt, chemically amplified negative resist composition, and pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-10-03 US disclosed
US-20230296980-A1 RESIST MATERIAL AND PATTERN FORMING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-21 US disclosed
US-20230296980-A1 RESIST MATERIAL AND PATTERN FORMING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-21 US disclosed
US-11747727-B2 Chemical liquid, chemical liquid storage body, pattern forming method, and kit FUJIFILM CORPORATION (JP) 2023-09-05 US disclosed
CN-110446770-B Reversible thermochromic composition and reversible thermochromic microcapsule pigment containing the same 百乐墨水株式会社 2023-08-08 CN disclosed
EP-0355772-B1 Liquid-crystalline copolymer IDEMITSU KOSAN CO (JP) 1993-12-29 EP disclosed
US-5248446-A Copolyethers from epoxy compounds, ferroelectricity IDEMITSU KOSAN CO., LTD. (JP) 1993-09-28 US disclosed
EP-0325035-B1 LIQUID CRYSTAL COMPOUND AND METHOD OF MANUFACTURING THE SAME, LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME AND LIQUID CRYSTAL DISPLAY DEVICE KABUSHIKI KAISHA TOSHIBA (JP) 1993-08-18 EP disclosed
US-5190686-A LIQUID-CRYSTALLINE COPOLYMER IDEMITSU KOSAN CO., LTD. (JP) 1993-03-02 US disclosed
EP-0258898-B1 LIQUID-CRYSTALLINE POLYMER IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-04-22 EP disclosed
US-4976887-A Optically active liquid crystal compound and method of manufacturing the same, liquid crystal composition containing the same and liquid crystal display device KABUSHIKI KAISHA TOSHIBA (JP) 1990-12-11 US disclosed
EP-0355772-A2 Liquid-crystalline copolymer IDEMITSU KOSAN COMPANY LIMITED (JP) 1990-02-28 EP disclosed
EP-0325035-A2 Liquid crystal compound and method of manufacturing the same, liquid crystal composition containing the same and liquid crystal display device KABUSHIKI KAISHA TOSHIBA (JP) 1989-07-26 EP disclosed
US-4818807-A Liquid-crystalline polymer IDEMITSU KOSAN CO., LTD. (JP) 1989-04-04 US disclosed
EP-0258898-A2 Liquid-crystalline polymer IDEMITSU KOSAN COMPANY LIMITED (JP) 1988-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773059-B2 Onium salt, chemically amplified negative resist composition, and pattern forming process LBR, IDUA, ADORA1 ELANE 2086/4885ESR1 1589/4885CA12 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.